₹210
(Inclusive of all Taxes)
₹31.5 Cashback (15%)
Prescription drugWhats That
19 people bought in last 30 days
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Composition :
KETOPROFEN-30MG
Manufacturer/Marketer :
Hetero Healthcare Pvt Ltd
Consume Type :
TOPICAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with K-Plast Transdermal Patches:
Coadministration of ketorolac together with K-Plast Transdermal Patches may increase the risk of side effects in the gastrointestinal tract such as inflammation, bleeding and ulcers.
How to manage the interaction:
Taking Ketorolac with K-Plast Transdermal Patches is not recommended, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience any unusual bleeding, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not discontinue any medications without consulting a doctor.
Coadministration of ketorolac together with K-Plast Transdermal Patches may increase the risk of side effects in the gastrointestinal tract such as inflammation, bleeding and ulcers.
How to manage the interaction:
Taking Ketorolac with K-Plast Transdermal Patches is not recommended, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience any unusual bleeding, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with K-Plast Transdermal Patches:
Everolimus can cause kidney issues, and taking it with K-Plast Transdermal Patches, can enhance the risk.
How to manage the interaction:
There may be a possibility of interaction between Everolimus and K-Plast Transdermal Patches, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not stop using any medications without talking to a doctor.
Everolimus can cause kidney issues, and taking it with K-Plast Transdermal Patches, can enhance the risk.
How to manage the interaction:
There may be a possibility of interaction between Everolimus and K-Plast Transdermal Patches, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with K-Plast Transdermal Patches:
Taking K-Plast Transdermal Patches with fondaparinux can increase the risk of bleeding complications.
How to manage the interaction:
Taking Fondaparinux with K-Plast Transdermal Patches together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience bleeding, severe back pain, dizziness, black or red stools, severe headache, weakness, and vomiting contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Taking K-Plast Transdermal Patches with fondaparinux can increase the risk of bleeding complications.
How to manage the interaction:
Taking Fondaparinux with K-Plast Transdermal Patches together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience bleeding, severe back pain, dizziness, black or red stools, severe headache, weakness, and vomiting contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Severe
How does the drug interact with K-Plast Transdermal Patches:
Coadministration of Naproxen and K-Plast Transdermal Patches can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Naproxen and K-Plast Transdermal Patches together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Coadministration of Naproxen and K-Plast Transdermal Patches can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Naproxen and K-Plast Transdermal Patches together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
How does the drug interact with K-Plast Transdermal Patches:
Taking Human immunoglobulin with K-Plast Transdermal Patches, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and K-Plast Transdermal Patches, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Taking Human immunoglobulin with K-Plast Transdermal Patches, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and K-Plast Transdermal Patches, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with K-Plast Transdermal Patches:
Combining K-Plast Transdermal Patches with Deferasirox can increase the risk of gastrointestinal bleeding and ulcers.
How to manage the interaction:
Co-administration of K-Plast Transdermal Patches with Deferasirox can possibly result in an interaction, but it can be taken if your doctor has advised it. This risk is higher in older people with certain blood disorders or low platelet counts.If you have symptoms like stomach pain, bloating, dizziness, or black stools, it's important to consult a doctor. Do not stop using any medications without a doctor's advice.
Combining K-Plast Transdermal Patches with Deferasirox can increase the risk of gastrointestinal bleeding and ulcers.
How to manage the interaction:
Co-administration of K-Plast Transdermal Patches with Deferasirox can possibly result in an interaction, but it can be taken if your doctor has advised it. This risk is higher in older people with certain blood disorders or low platelet counts.If you have symptoms like stomach pain, bloating, dizziness, or black stools, it's important to consult a doctor. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with K-Plast Transdermal Patches:
Taking K-Plast Transdermal Patches with Glimepiride may increase the risk of hypoglycemia (low blood sugar).
How to manage the interaction:
Although there is a possible interaction, Glimepiride can be taken with K-Plast Transdermal Patches if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Do not taking the medications without consulting a doctor.
Taking K-Plast Transdermal Patches with Glimepiride may increase the risk of hypoglycemia (low blood sugar).
How to manage the interaction:
Although there is a possible interaction, Glimepiride can be taken with K-Plast Transdermal Patches if prescribed by the doctor. Consult the prescriber if you experience symptoms of low blood sugar such as headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea, hunger, weakness, perspiration, palpitation, and rapid heartbeat. Do not taking the medications without consulting a doctor.
Severe
How does the drug interact with K-Plast Transdermal Patches:
The combined use of Indometacin and K-Plast Transdermal Patches can increase the risk of side effects in the gastrointestinal tract such as inflammation, bleeding, ulceration, and rarely, perforation.
How to manage the interaction:
Taking Indometacin with K-Plast Transdermal Patches together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor. Do not stop using any medications without a doctor's advice.
The combined use of Indometacin and K-Plast Transdermal Patches can increase the risk of side effects in the gastrointestinal tract such as inflammation, bleeding, ulceration, and rarely, perforation.
How to manage the interaction:
Taking Indometacin with K-Plast Transdermal Patches together can possibly result in an interaction, but it can be taken if your doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with K-Plast Transdermal Patches:
Coadministration of K-Plast Transdermal Patches and Apixaban co-administration may raise the risk of bleeding.
How to manage the interaction:
Even though combining K-Plast Transdermal Patches and Apixaban may cause an interaction, it is still possible to take it if your doctor advises you to. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Without consulting a doctor, never stop taking any medications.
Coadministration of K-Plast Transdermal Patches and Apixaban co-administration may raise the risk of bleeding.
How to manage the interaction:
Even though combining K-Plast Transdermal Patches and Apixaban may cause an interaction, it is still possible to take it if your doctor advises you to. Consult a doctor if you experience symptoms like blood in your urine or stool (or a black stool), severe bruising, prolonged nosebleeds, feeling dizzy or lightheaded, weakness or severe headache, vomiting blood or coughing up blood, heavy menstrual bleeding (in women), difficulty breathing, or chest pain. Without consulting a doctor, never stop taking any medications.
Severe
How does the drug interact with K-Plast Transdermal Patches:
Co-administration of Ibrutinib with K-Plast Transdermal Patches can increase the risk of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Ibrutinib with K-Plast Transdermal Patches together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor. Do not stop using any medications without a doctor's advice.
Co-administration of Ibrutinib with K-Plast Transdermal Patches can increase the risk of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Ibrutinib with K-Plast Transdermal Patches together can result in an interaction, but it can be taken if a doctor has advised it. However, if you experience unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult a doctor. Do not stop using any medications without a doctor's advice.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
K-Plast Transdermal Patches Substitute
Product Substitutes
Alcohol
Caution
It is unknown if alcohol affects K-Plast Transdermal Patches. However, as a precautionary measure, it is advisable to limit or avoid the consumption of alcohol.
Pregnancy
Caution
There are no adequate and well-controlled studies on the use of this medication in pregnant women. Please inform your doctor if you are pregnant or planning to become pregnant. Your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Consult your doctor
Limited information is available on the effect of K-Plast Transdermal Patches on breastfeeding women. Tell your doctor if you are a nursing mother before taking K-Plast Transdermal Patches; your doctor will decide whether breastfeeding mothers can take K-Plast Transdermal Patches.
Driving
Not applicable
It does not impact your ability to drive or operate machinery.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving K-Plast Transdermal Patches. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.
Kidney
Caution
If you have a pre-existing history of kidney disease, inform your doctor before receiving K-Plast Transdermal Patches. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.
Children
Caution
K-Plast Transdermal Patches is not recommended for children as safety and effectiveness have not been established.
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
